Florida Cancer Specialists & Research Institute Among First in Florida to Trial Next-Generation Immunotherapy for Castration-Resistant Prostate Cancer

Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to ...
Mena FN

Prostate Cancer Pipeline And Competitive Landscape: 150+ Companies, 160+ Therapies, And The Next Wave Of FDA-Backed Innovation, Analyses Delveinsight

"Prostate Cancer Pipeline"Leading organizations including Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui ...
EurekAlert!

First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer

SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone ...